2024-08-23 15:55:02
UTime Limited (NASDAQ: WTO) (“UTime” or the “Company”) is pleased to announce plans to participate in a number of internationally recognized medical trade shows and professional conferences. The upcoming event provides UTime with a valuable opportunity to showcase its latest achievements in medical devices and medical solutions and strengthen its communication and partnerships within the global medical industry.
At the upcoming MEDICA, one of the world’s most influential medical technology and equipment trade fairs, in Dusseldorf, UTime plans to showcase its latest innovations in medical monitoring equipment and smart diagnostic tools. The company’s stand is designed to showcase its pioneering work across the entire value chain of medical technology products.
In addition to MEDICA, UTime also plans to attend the American Heart Association conference, sleep conference and hypertension conference. These conferences bring together leading medical experts and scientists and not only provide UTime with a platform to showcase its technological advancements to the industry, but also provide an excellent opportunity to learn from colleagues around the world and gain important insights.
Participation in these programs underscores UTime’s ongoing commitment to impacting the global medical and healthcare landscape and demonstrates the company’s mission to improve human health through technological innovation.
UTime also intends to explore possible collaborative projects with various international health organizations and research institutions, especially in the areas of telemedicine and the application of artificial intelligence in healthcare. Through such international collaborations, the company aims to accelerate the global promotion of its products, ultimately benefiting patients around the world.
Information about UTime Ltd.
UTime is committed to improving health and well-being through innovative medical wearable technology. By leveraging cutting-edge research and strategic partnerships, UTime aims to provide effective solutions for disease prevention and health management worldwide. For more information, visit the company’s website: http://www.utimeworld.com/.
forward-looking statements
Statements in this press release regarding future expectations, plans and prospects and any other statements regarding matters that are not historical facts may constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and U.S. Private Securities Exchange Litigation Reform Act of 1995 “anticipates”, “believes”, “continues”, “could”, “estimates”, “anticipates”, “intends”, “may”, “plans”, “potential” and other words, ” The words “forecast,” “project,” “should,” “target,” “will,” “will” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may vary due to various important factors discussed in the “Risk Factors” section of the Company’s annual report on Form 20-F filed with the Securities and Exchange Commission on July 30, 2024, and may differ from those contained in such report. There are significant differences in the included results. Any forward-looking statements contained in this press release speak only as of the date of this press release, and the Company expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information please contact:
Iggy Tan
1724460428
#UTime #Limited #participates #international #medical #exhibitions #medical #conferences
